- Report
- November 2026
- 239 Pages
Global
From €5424EUR$5,850USD£4,537GBP
- Report
- November 2026
- 215 Pages
Global
From €5424EUR$5,850USD£4,537GBP
- Report
- November 2026
- 422 Pages
Global
From €5424EUR$5,850USD£4,537GBP
- Report
- November 2026
- 345 Pages
Global
From €5424EUR$5,850USD£4,537GBP
- Report
- November 2026
- 573 Pages
Global
From €5424EUR$5,850USD£4,537GBP
- Report
- August 2026
- 120 Pages
Global
From €4404EUR$4,750USD£3,684GBP
- Report
- August 2026
- 110 Pages
Global
From €4404EUR$4,750USD£3,684GBP
- Report
- July 2026
- 112 Pages
Global
From €4404EUR$4,750USD£3,684GBP
- Report
- July 2026
- 135 Pages
Global
From €4404EUR$4,750USD£3,684GBP
- Report
- January 2026
- 120 Pages
Global
From €4404EUR$4,750USD£3,684GBP
- Report
- August 2026
- 185 Pages
Global
From €4404EUR$4,750USD£3,684GBP
- Report
- August 2026
- 110 Pages
Global
From €4404EUR$4,750USD£3,684GBP
- Report
- July 2026
- 115 Pages
Global
From €4404EUR$4,750USD£3,684GBP
- Report
- April 2026
- 180 Pages
Global
From €4404EUR$4,750USD£3,684GBP
- Report
- August 2026
- 181 Pages
Global
From €3662EUR$3,950USD£3,063GBP
- Report
- February 2026
- 147 Pages
Global
From €3662EUR$3,950USD£3,063GBP
- Report
- January 2026
- 144 Pages
Global
From €3662EUR$3,950USD£3,063GBP
- Report
- January 2026
- 140 Pages
Global
From €3662EUR$3,950USD£3,063GBP
- Report
- October 2026
- 160 Pages
Global
From €3078EUR$3,320USD£2,575GBP
€3848EUR$4,150USD£3,218GBP
- Report
- August 2026
- 160 Pages
Global
From €3078EUR$3,320USD£2,575GBP
€3848EUR$4,150USD£3,218GBP

Pharmacogenomics is a field of genomics that studies the relationship between an individual's genetic makeup and their response to drugs. It is used to develop personalized medicine, which is tailored to an individual's genetic profile. This field of genomics has the potential to revolutionize the way drugs are developed and prescribed, as it can help to identify which drugs are most effective for a particular patient. It can also help to reduce the risk of adverse drug reactions, as well as reduce the cost of drug development.
Pharmacogenomics is a rapidly growing field, with many companies investing in research and development. Examples of companies in the market include 23andMe, Genomics England, and Illumina. Show Less Read more